Alprostadil associated with low molecular weight heparin to treat limb ischemia caused by SARS-CoV2 / Alprostadil associado a heparina de baixo peso molecular para o tratamento da isquemia de membros causada por SARS-CoV2
Manhanelli Filho, Marcos Antonio Bonacorso; Duarte Júnior, Eliud Garcia; Mariuba, Jamil Victor de Oliveira; Linardi, Fábio; Costa, José Augusto; Gali, Julio Cesar; Yoshida, Winston Bonetti; Gali Filho, Julio Cesar.
J. vasc. bras
; 19: e20200072, 2020. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-1143212
Abstract The current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19.
Biblioteca responsable:
BR1.1
Texto completo
Documentos relacionados